Loading viewer...
conference
Format: PDF conference
Regeneron presented its strategy and business update at the J.P. Morgan Healthcare Conference in January 2024, showcasing its portfolio of marketed products including EYLEA, Dupixent, and Libtayo, alongside late-stage and investigational candidates. The presentation covered pipeline programs, clinical milestones, manufacturing initiatives, and commercial progress across oncology, immunology, and other therapeutic areas.
investor_presentation
23 Pages
conference
30 Pages
Etrion
ASR Nederland 2017 Bank of America Merrill Lynch Conference
conferenceconference
22 Pages
a.s.r. (ASR Nederland N.V.)
Central Pattana 2024 Thailand Investor Conference
conferenceconference
67 Pages
Central Pattana Public Company